Cargando…

Participation of Gα(i)-Adenylate Cyclase and ERK1/2 in Mas Receptor Signaling Pathways

The MasR receptor (MasR) is an orphan G protein-coupled receptor proposed as a candidate for mediating the angiotensin (Ang)-converting enzyme 2-Ang-(1–7) protective axis of renin-angiotensin system. This receptor has been suggested to participate in several physiological processes including cardio-...

Descripción completa

Detalles Bibliográficos
Autores principales: Burghi, Valeria, Echeverría, Emiliana B., Sosa, Máximo H., Quiroga, Diego T., Muñoz, Marina C., Davio, Carlos, Monczor, Federico, Fernández, Natalia C., Dominici, Fernando P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395383/
https://www.ncbi.nlm.nih.gov/pubmed/30853914
http://dx.doi.org/10.3389/fphar.2019.00146
_version_ 1783399080617050112
author Burghi, Valeria
Echeverría, Emiliana B.
Sosa, Máximo H.
Quiroga, Diego T.
Muñoz, Marina C.
Davio, Carlos
Monczor, Federico
Fernández, Natalia C.
Dominici, Fernando P.
author_facet Burghi, Valeria
Echeverría, Emiliana B.
Sosa, Máximo H.
Quiroga, Diego T.
Muñoz, Marina C.
Davio, Carlos
Monczor, Federico
Fernández, Natalia C.
Dominici, Fernando P.
author_sort Burghi, Valeria
collection PubMed
description The MasR receptor (MasR) is an orphan G protein-coupled receptor proposed as a candidate for mediating the angiotensin (Ang)-converting enzyme 2-Ang-(1–7) protective axis of renin-angiotensin system. This receptor has been suggested to participate in several physiological processes including cardio- and reno-protection and regulation of the central nervous system function. Although the knowledge of the signaling mechanisms associated with MasR is essential for therapeutic purposes, these are still poorly understood. Accordingly, in the current study we aimed to characterize the signaling pathways triggered by the MasR. To do that, we measured cAMP and Ca(2+) levels in both naïve and MasR transfected cells in basal conditions and upon incubation with putative MasR ligands. Besides, we evaluated activation of ERK1/2 by Ang-(1–7) in MasR transfected cells. Results indicated the existence of a high degree of MasR constitutive activity toward cAMP modulation. This effect was not mediated by the PDZ-binding motif of the MasR but by receptor coupling to Gαi-adenylyl cyclase signaling pathway. Incubation of MasR transfected cells with Ang-(1–7) or the synthetic ligand AVE 0991 amplified MasR negative modulation of cAMP levels. On the other hand, we provided evidence for lack of MasR-associated modulation of Ca(2+) levels by Ang-(1–7). Finally, it was determined that the MasR attenuated Ang-(1–7)-induced ERK1/2 phosphorylation mediated by AT1R. We provided further characterization of MasR signaling mechanisms regarding its constitutive activity and response to putative ligands. This information could prove useful to better describe MasR physiological role and development of therapeutic agents that could modulate its action.
format Online
Article
Text
id pubmed-6395383
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-63953832019-03-08 Participation of Gα(i)-Adenylate Cyclase and ERK1/2 in Mas Receptor Signaling Pathways Burghi, Valeria Echeverría, Emiliana B. Sosa, Máximo H. Quiroga, Diego T. Muñoz, Marina C. Davio, Carlos Monczor, Federico Fernández, Natalia C. Dominici, Fernando P. Front Pharmacol Pharmacology The MasR receptor (MasR) is an orphan G protein-coupled receptor proposed as a candidate for mediating the angiotensin (Ang)-converting enzyme 2-Ang-(1–7) protective axis of renin-angiotensin system. This receptor has been suggested to participate in several physiological processes including cardio- and reno-protection and regulation of the central nervous system function. Although the knowledge of the signaling mechanisms associated with MasR is essential for therapeutic purposes, these are still poorly understood. Accordingly, in the current study we aimed to characterize the signaling pathways triggered by the MasR. To do that, we measured cAMP and Ca(2+) levels in both naïve and MasR transfected cells in basal conditions and upon incubation with putative MasR ligands. Besides, we evaluated activation of ERK1/2 by Ang-(1–7) in MasR transfected cells. Results indicated the existence of a high degree of MasR constitutive activity toward cAMP modulation. This effect was not mediated by the PDZ-binding motif of the MasR but by receptor coupling to Gαi-adenylyl cyclase signaling pathway. Incubation of MasR transfected cells with Ang-(1–7) or the synthetic ligand AVE 0991 amplified MasR negative modulation of cAMP levels. On the other hand, we provided evidence for lack of MasR-associated modulation of Ca(2+) levels by Ang-(1–7). Finally, it was determined that the MasR attenuated Ang-(1–7)-induced ERK1/2 phosphorylation mediated by AT1R. We provided further characterization of MasR signaling mechanisms regarding its constitutive activity and response to putative ligands. This information could prove useful to better describe MasR physiological role and development of therapeutic agents that could modulate its action. Frontiers Media S.A. 2019-02-22 /pmc/articles/PMC6395383/ /pubmed/30853914 http://dx.doi.org/10.3389/fphar.2019.00146 Text en Copyright © 2019 Burghi, Echeverría, Sosa, Quiroga, Muñoz, Davio, Monczor, Fernández and Dominici. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Burghi, Valeria
Echeverría, Emiliana B.
Sosa, Máximo H.
Quiroga, Diego T.
Muñoz, Marina C.
Davio, Carlos
Monczor, Federico
Fernández, Natalia C.
Dominici, Fernando P.
Participation of Gα(i)-Adenylate Cyclase and ERK1/2 in Mas Receptor Signaling Pathways
title Participation of Gα(i)-Adenylate Cyclase and ERK1/2 in Mas Receptor Signaling Pathways
title_full Participation of Gα(i)-Adenylate Cyclase and ERK1/2 in Mas Receptor Signaling Pathways
title_fullStr Participation of Gα(i)-Adenylate Cyclase and ERK1/2 in Mas Receptor Signaling Pathways
title_full_unstemmed Participation of Gα(i)-Adenylate Cyclase and ERK1/2 in Mas Receptor Signaling Pathways
title_short Participation of Gα(i)-Adenylate Cyclase and ERK1/2 in Mas Receptor Signaling Pathways
title_sort participation of gα(i)-adenylate cyclase and erk1/2 in mas receptor signaling pathways
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395383/
https://www.ncbi.nlm.nih.gov/pubmed/30853914
http://dx.doi.org/10.3389/fphar.2019.00146
work_keys_str_mv AT burghivaleria participationofgaiadenylatecyclaseanderk12inmasreceptorsignalingpathways
AT echeverriaemilianab participationofgaiadenylatecyclaseanderk12inmasreceptorsignalingpathways
AT sosamaximoh participationofgaiadenylatecyclaseanderk12inmasreceptorsignalingpathways
AT quirogadiegot participationofgaiadenylatecyclaseanderk12inmasreceptorsignalingpathways
AT munozmarinac participationofgaiadenylatecyclaseanderk12inmasreceptorsignalingpathways
AT daviocarlos participationofgaiadenylatecyclaseanderk12inmasreceptorsignalingpathways
AT monczorfederico participationofgaiadenylatecyclaseanderk12inmasreceptorsignalingpathways
AT fernandeznataliac participationofgaiadenylatecyclaseanderk12inmasreceptorsignalingpathways
AT dominicifernandop participationofgaiadenylatecyclaseanderk12inmasreceptorsignalingpathways